STING1 and amyotrophic lateral sclerosis: However, increasing evidence implicates dysregulation of the cGAS-STING pathway in neurological disorders, including multiple sclerosis15, Parkinson’s disease16, amyotrophic lateral sclerosis (ALS)17, Huntington’s disease18, and recently, amyloidosis19 and tauopathy20.